Quality Specialty Pharmacy

QualitySpecialtyPharmacy.com

Quality Specialty Pharmacy is a specialty pharmacy providing medication management and pharmacy services in the United States since 2005. We offer biotech and specialty pharmaceuticals, medication management programs, patient monitoring, extensive reporting and expert patient support services. Personalized medication management programs and services are available in the areas of gastroenterology, rheumatology, dermatology, endocrinology, HIV/AIDS, transplant, neurology, nephrology, oncology and IVIG.. We serve patients nationwide and are involved in clinical trials and national testing initiatives. Quality Specialty Pharmacy's hubs are Bronx, New York, Hyde Park, Massachusetts, Tampa, Florida, and Lomita, California.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT

EditForce, Inc. | July 06, 2022

news image

EditForce, Inc. has entered into a License Agreement with Mitsubishi Tanabe Pharma Corporation to research, develop and commercialize potential gene therapy products for a specific target disease in the field of CNS by utilizing EditForce's proprietary PPR protein platform technology. In this alliance, MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing the drug R&D know-how and global business experience of MTPC and t...

Read More

MEDIDATA, TRINETX, AND DATAVANT PARTNER TO ENABLE SEAMLESS INTEGRATION OF REAL-WORLD DATA IN CLINICAL DEVELOPMENT

Medidata | October 30, 2020

news image

Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to power clinical research. Linking RWD, which are data not collected during the specific context of the trial, can help improve understanding of the long-term safety and efficacy of new therapies. This partnership will enable users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de...

Read More

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

news image

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More

Business Insights, PHARMACY MARKET

CURIA COLLABORATES WITH CORNING TO ADVANCE BIOPHARMACEUTICAL CONTINUOUS-FLOW DEVELOPMENT AND MANUFACTURING PROGRAMS

Globenewswire | March 24, 2023

news image

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration with Corning’s Advanced-Flow™ Reactor (AFR) team includes the first installation of Corning’s G1 production system, designed for the continuous industrial production of active phar...

Read More
news image

Business Insights

EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT

EditForce, Inc. | July 06, 2022

EditForce, Inc. has entered into a License Agreement with Mitsubishi Tanabe Pharma Corporation to research, develop and commercialize potential gene therapy products for a specific target disease in the field of CNS by utilizing EditForce's proprietary PPR protein platform technology. In this alliance, MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing the drug R&D know-how and global business experience of MTPC and t...

Read More
news image

MEDIDATA, TRINETX, AND DATAVANT PARTNER TO ENABLE SEAMLESS INTEGRATION OF REAL-WORLD DATA IN CLINICAL DEVELOPMENT

Medidata | October 30, 2020

Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to power clinical research. Linking RWD, which are data not collected during the specific context of the trial, can help improve understanding of the long-term safety and efficacy of new therapies. This partnership will enable users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de...

Read More
news image

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More
news image

Business Insights, PHARMACY MARKET

CURIA COLLABORATES WITH CORNING TO ADVANCE BIOPHARMACEUTICAL CONTINUOUS-FLOW DEVELOPMENT AND MANUFACTURING PROGRAMS

Globenewswire | March 24, 2023

Curia, a leading contract research, development and manufacturing organization, today announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration with Corning’s Advanced-Flow™ Reactor (AFR) team includes the first installation of Corning’s G1 production system, designed for the continuous industrial production of active phar...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us